Skip to main content
NBIX logo

NBIX · Neurocrine Biosciences Inc · Debt

Track NBIX — free
$142.43 +0.43 (+0.30%)
Market Cap
$14.43B
Shares
101.65M
Volume · Oct 21 12.16K Avg daily vol (3M) 1.32M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Operating lease liabilities 2026-06-30 USD 461,600,000 10-Q filed 2026-07-31
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 59,800,000
Noncurrent operating lease liabilities
USD 401,800,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 914475 CUSIP 64125C109 13F (30d) 124 filings 115 filers Visit website Investor relations